WeVote
Log In

Bill

Bill

HB 1275

Medical practice; ensure that stem cell therapies are used to advance medical treatments and improve patient outcomes in an ethical manner that does not involve stem cells derived from aborted fetuses

2025-2026 Regular Session Introduced by Michelle Au and 4 co-sponsors

Georgia bill prohibits stem cell therapies derived from aborted fetuses while permitting other stem cell medical treatments to advance patient care ethically.

Act 453
#professionsandbusinesses
0
WeVote Research Nonpartisan
Bill Summary · HB 1275

Legislative bill overview

HB 1275 would regulate stem cell therapies in Georgia by prohibiting medical practices from using stem cells derived from aborted fetuses while permitting other stem cell research and treatments. The bill aims to establish ethical guidelines for stem cell medicine advancement within the state.

Why is this important

Stem cell therapies represent a frontier in treating diseases like Parkinson's, diabetes, and spinal cord injuries, making regulatory clarity significant for medical innovation. The bill directly addresses the intersection of medical practice, reproductive ethics, and patient access to emerging treatments—areas where different stakeholders hold deeply held convictions.

Potential points of contention

  • Definition and enforcement challenges: The bill must clearly define what qualifies as "aborted fetus" stem cells versus other pluripotent stem cell sources (induced pluripotent stem cells, umbilical cord, adult stem cells), which have different ethical profiles and scientific capabilities
  • Scientific efficacy limitations: Some stem cell therapies currently in development or showing promise may have originated from fetal tissue research; restricting these could limit patient access to potentially life-saving treatments
  • Competitive disadvantage: Stricter regulations in Georgia compared to other states or nations could drive stem cell research and biotech companies elsewhere, potentially affecting the state's medical innovation economy and patient access

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.